{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:47:48Z","timestamp":1788223668559,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081652"],"award-info":[{"award-number":["6H79TI081652"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Educ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Morbidity and mortality from Opioid Use Disorder is a health crisis in the United States. During the COVID-19 pandemic, there was a devastating increase of 38.4% in overdose deaths from the 12-month period leading up to June 2019 compared with the 12-month period leading up to May 2020, primarily driven by synthetic opioids. Buprenorphine is an effective medication for opioid use disorder but uptake is slow due in part to lack of provider knowledge, confidence, and negative attitudes\/stigma toward patients with OUD. Addressing these barriers in academic training is a promising approach to building workforce able to effectively treat opioid use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our university developed a training for pre-licensure physicians, physician assistants and psychiatric nurse practitioners that included the DATA Waiver training and a shadowing experience. Expected outcomes included improved knowledge, skills and attitudes about persons with OUD and buprenorphine treatment, plans to provide this treatment post-graduation, for pre-licensure learners to have completed all requirements to prescribe buprenorphine post-graduation, and for the training to be embedded into school\u2019s curricula.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results were positive overall including improved knowledge and attitudes toward persons with OUD, better understanding of the benefits of this treatment for patients, increased confidence and motivation to provide this treatment post-graduation. The training is now embedded in each program\u2019s graduation requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Developing a didactic and experiential training on buprenorphine treatment for opioid use disorder and embedding it into medical, physician assistant, and psychiatric nurse practitioner licensure programs can help prepare future providers to treat opioid use disorder in a range of settings. Key to replicating this program in other university settings is to engage faculty members who actively provide treatment to persons with OUD to ensure shadowing opportunities and serve as role models for learners.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12909-023-04088-5","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T04:03:04Z","timestamp":1677643384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation and guide for embedding opioid use disorder education in health professions\u2019 curricula"],"prefix":"10.1186","volume":"23","author":[{"given":"Julie G.","family":"Salvador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindy L.","family":"Bola\u00f1os-Sacoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna G.","family":"Katzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay E.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal R.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler W.","family":"Kincaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Ann","family":"Waldorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"4088_CR1","unstructured":"CDC., 2021. Centers for Disease Control and Prevention, Injury Center, Drug Overdose. Drug Overdose Deaths Remain High. Available at https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html#:~. Accessed January 30,2023."},{"key":"4088_CR2","unstructured":"CDC, National Center for Health Statistics., 2021. Centers for Disease Control and Prevention,. Drug Overdose Deaths in the U.S. Top 100,000 Annually. Available at https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm Accessed April 8, 2022."},{"key":"4088_CR3","unstructured":"SAMHSA., 2017. Substance Abuse and Mental Health Services Administration. SAMSHA Reaffirms Efforts to Address the Public Health Emergency on the Opioid Crisis [Webpage]. https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/201710260100 Accessed September 7, 2021."},{"key":"4088_CR4","unstructured":"NIDA. 2021. Overview. National Institute on Drug Abuse [Webpage]. Available at https:\/\/www.drugabuse.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/overview. Accessed September 9, 2021."},{"key":"4088_CR5","unstructured":"NIDA. 2016, November 1. Effective Treatments for Opioid Addiction. Available at [Webpage]https:\/\/www.drugabuse.gov\/publications\/effective-treatments-opioid-addiction. Accessed September 9, 2021"},{"key":"4088_CR6","unstructured":"California Health Foundation. Recovery Within Reach: Medication Assisted Treatment of Opioid Addiction Comes to Primary Care [Webpage] Available at https:\/\/www.chcf.org\/wp-content\/uploads\/2017\/12\/PDF-RecoveryReachMAT.pdf Accessed September 19, 2016."},{"key":"4088_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","volume":"34","author":"HK Nudsen","year":"2011","unstructured":"Nudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011;34:375\u201381. https:\/\/doi.org\/10.1016\/j.evalprogplan.2011.02.004.","journal-title":"Eval Program Plann"},{"key":"4088_CR8","unstructured":"Substance Abuse and Mental Health Services Administration. Medication-assisted treatment\u2014Practitioner and program data [Webpage]. Available at: https:\/\/www.samhsa.gov\/medication-assisted-treatment\/training-materials-resources\/practitioner-program-data. Accessed April 29, 2020."},{"key":"4088_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.12307","volume":"35","author":"CHA Andrilla","year":"2019","unstructured":"Andrilla CHA, Moore TE, Patterson DG, et al. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health. 2019;35:108\u201312. https:\/\/doi.org\/10.1111\/jrh.12307.","journal-title":"J Rural Health"},{"key":"4088_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1802741","volume":"379","author":"SE Wakeman","year":"2018","unstructured":"Wakeman SE, Barnett ML. Primary care and the opioid-overdose crisis \u2013 buprenorphine myths and realities. N Engl J Med. 2018;379:1\u20134. https:\/\/doi.org\/10.1056\/NEJMp1802741.","journal-title":"N Engl J Med"},{"key":"4088_CR11","unstructured":"Bloom BS, Engelhart MD, Furst EJ, Hill WH, Krathwohl DR. Taxonomy of educational objectives: The classification of educational goals. Handbook I: Cognitive domain. New York: David McKay Company. 1956"},{"key":"4088_CR12","doi-asserted-by":"publisher","unstructured":"Arora S, Thornton K, Murata G et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011; 364:2199-2207 doi: https:\/\/doi.org\/10.1056\/NEJMoa1009370","DOI":"10.1056\/NEJMoa1009370"},{"issue":"4","key":"4088_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/08897077.2020.1806184","volume":"42","author":"JG Salvador","year":"2021","unstructured":"Salvador JG, Bhatt SR, Jacobsohn VC, Maley LA, Alkhafaji RS, Rishel Brakey H, Myers OB, Sussman AL. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports. Subst Abus. 2021;42(4):610\u20137. Epub 2020 Aug 19. PMID: 32814005; PMCID: PMC8552422.","journal-title":"Subst Abus"},{"key":"4088_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/08897077.2019.1692323","volume":"41","author":"E Zerbo","year":"2020","unstructured":"Zerbo E, Traba C, Matthew P, et al. DATA 2000 waiver training for medical students: Lessons learned from a medical school experience. Subst Abus. 2020;41:463\u20137. https:\/\/doi.org\/10.1080\/08897077.2019.1692323.","journal-title":"Subst Abus"},{"issue":"4","key":"4088_CR15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/08897077.2021.1915918","volume":"42","author":"PM Estave","year":"2021","unstructured":"Estave PM, Jacobs ML, Rukstalis M, Goforth J, Stone SN, Choi JA, Barrett J, Douglas HE, Oliver JB, Keating MK, Freischlag JA, O\u2019Brien MC, McEwen S, Strowd RE. Opioid stewardship training during the transition to Residency to prepare medical students to recognize and treat opioid Use Disorder. Subst Abuse. 2021;42(4):1040\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/34236292\/.","journal-title":"Subst Abuse"},{"key":"4088_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/08897077.2021.1903653","volume":"42","author":"E Riser","year":"2021","unstructured":"Riser E, Holterman LA, Maruti S, et al. Integrating DATA 2000 waiver training into undergraduate medical education: the time is now. Subst Abus. 2021;42:236\u201343. https:\/\/doi.org\/10.1080\/08897077.2021.1903653.","journal-title":"Subst Abus"},{"issue":"2","key":"4088_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/ACM.0000000000003968","volume":"97","author":"D Stokes","year":"2022","unstructured":"Stokes D, Perrone J. Increasing short- and long-term Buprenorphine Treatment Capacity: providing Waiver Training for Medical Students. Acad Med. 2022;97(2):182\u20137. https:\/\/doi.org\/10.1097\/ACM.0000000000003968.","journal-title":"Acad Med"},{"issue":"1","key":"4088_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10872981.2020.1847755","volume":"26","author":"I Lien","year":"2020","unstructured":"Lien I, Seaton R, Szpytman A, Chou J, Webber V, Waineo E, Levine D. Eight-hour medication-assisted treatment Waiver Training for Opioid Use Disorder: integration into Medical School Curriculum. Med Educ Online. 2020;26(1):1\u20134. https:\/\/doi.org\/10.1080\/10872981.2020.1847755. https:\/\/www.tandfonline.com\/doi\/pdf\/.","journal-title":"Med Educ Online"}],"container-title":["BMC Medical Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-023-04088-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12909-023-04088-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-023-04088-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T04:05:35Z","timestamp":1677643535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmededuc.biomedcentral.com\/articles\/10.1186\/s12909-023-04088-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1186\/s12909-023-04088-5","relation":{},"ISSN":["1472-6920"],"issn-type":[{"value":"1472-6920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of New Mexico, Human Research Protections Office (approval # HRPO 19\u2013491). All methods were carried out in accordance with relevant guidelines and regulations. Informed consent to participate was obtained from all study subjects and\/or their legal guardians, as per the UNM HRPO which follows all relevant human research guidelines and regulations and who approved of the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"VW, JS, LF, AE, and JK supported this initiative through their leadership roles in health education programming at the University (e.g., Medical School, Physician Education, and Nursing). VW, JS, LF, AE, JK and SB also provide direct services to persons with opioid use disorder and serve as champions for this initiative. As described in the manuscript, developing this intervention and evaluation relied on the professional positions and personal commitment (\u201cchampions\u201d) of these authors. SBS, TK and JS are non-clinical and work in research and evaluation in the field of substance use disorders, and opioid use disorder.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All authors declare they have no conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. This research was approved by the University of New Mexico, Human Research Protections Office.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement and IRB approval"}}],"article-number":"135"}}